Prot #CBI-2017-CMP-002: Performance of the DecisionDx-Melanoma Gene Expression Profile Test for Prognosis of Recurrence Risk

Project: Research project

Project Details

StatusActive
Effective start/end date2/5/182/5/21

Funding

  • Castle Biosciences, Inc. (Prot #CBI-2017-CMP-002)